Sanofi (SNY) Change in Inventory (2013 - 2021)
Sanofi's (SNY) quarterly Change in Inventory came in at $16.0 million in Q4 2021, up 116.66% year-on-year from $7.4 million in Q4 2020, and up 116.66% quarter-over-quarter from $7.4 million in Q4 2020.
Sanofi (SNY) Change in Inventory (2013 - 2021) Analysis & Trends
Sanofi has disclosed Change in Inventory across 4 years of filings, most recently posting $16.0 million for Q4 2021.
- Change in Inventory for Q4 2021 came in at $16.0 million, up 116.66% year-over-year; the trailing twelve-month figure through Dec 2021 was $693.3 million (changed N/A YoY), and the FY2025 annual result was -$45.4 million, up 91.09% from the prior year.
- Change in Inventory came in at $16.0 million for Q4 2021 at Sanofi, up from $7.4 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $16.0 million in Q4 2021 to a low of $1.3 million in Q4 2019.
- The 3-year median for Change in Inventory is $7.4 million (2020), against an average of $8.2 million.
- Across the five-year window, Change in Inventory jumped 456.53% in 2020 and soared 116.66% in 2021, its largest moves.
- Sanofi's Change in Inventory stood at $1.3 million in 2019, then surged by 456.53% to $7.4 million in 2020, then jumped by 116.66% to $16.0 million in 2021.
- The last three Change in Inventory figures came in at $16.0 million (Q4 2021), $7.4 million (Q4 2020), and $1.3 million (Q4 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 431.00 Mn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 184.00 Mn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | - |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | -18.00 Mn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 52.00 Mn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | -14.00 Mn |
| 10 | Sanofi | 63.47 Mn | -6.87 Bn | 9.49 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 16.02 Mn |
| Dec 31, 2021 | 16.02 Mn |
| Dec 31, 2020 | 7.39 Mn |
| Dec 31, 2020 | 7.39 Mn |
| Dec 31, 2019 | 1.33 Mn |
| Dec 31, 2019 | 1.33 Mn |
| Jun 30, 2013 | 668.55 Mn |
| Jun 30, 2013 | 668.55 Mn |